12:55 PM EDT, 10/24/2024 (MT Newswires) -- Conduit Pharmaceuticals ( CDT ) shares were down more than 4% in recent Thursday trading, a day after it filed a registration statement with the US Securities and Exchange Commission covering the potential sale of up to $100 million of its securities from time to time in one or more offerings.

The filing covers common stock, preferred stock, warrants, and units.

Price: 0.13, Change: -0.01, Percent Change: -4.39